Quoin Pharmaceuticals, Ltd. has an official-source baseline, but the report keeps the decision focused on filings: revenue quality, operating income, cash conversion, balance-sheet risk and the next update.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-27 · Confirms QNRX ticker, listed issuer name, exchange and CIK where available.SEC APISEC submissions for Quoin Pharmaceuticals, Ltd.Retrieved 2026-05-27 · Company identity, filing chronology, fiscal year end, SIC description, addresses and latest filing metadata.SEC XBRL APISEC companyfacts for Quoin Pharmaceuticals, Ltd.Retrieved 2026-05-27 · XBRL-derived revenue, profit, cash-flow and balance-sheet cross-checks when tagged facts are available.10-KQuoin Pharmaceuticals, Ltd. annual report2026-03-26 · annual report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.10-QQuoin Pharmaceuticals, Ltd. latest quarterly or interim report2026-05-07 · latest quarterly or interim report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.8-KQuoin Pharmaceuticals, Ltd. current report2026-05-07 · current report. Used for business description, risk factors, financial statement context, governance chronology or recent event review.DEF 14AQuoin Pharmaceuticals, Ltd. proxy statement2025-07-17 · proxy statement. Used for business description, risk factors, financial statement context, governance chronology or recent event review.